Daratumumab and dexamethasone is safe and effective for triple refractory myeloma patients: final results of the IFM 2014-04 (Etoile du Nord) trial

IFM2014-04 investigators

Research output: Contribution to journalArticlepeer-review

17 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Daratumumab and dexamethasone is safe and effective for triple refractory myeloma patients: final results of the IFM 2014-04 (Etoile du Nord) trial'. Together they form a unique fingerprint.

Medicine & Life Sciences